Somatogen's P2P Acquisition

Somatogen raised a round of funding on February 26, 1998. Investors include Baxter International.

Somatogen, a biopharmaceutical company, develops specialty oxygen therapeutics and other pharmacological agents utilizing its proprietary recombinant hemoglobin technology.…

Articles about Somatogen's P2P Acquisition: